The gastric balloon refers to a developed medical
device that is efficiently utilized in an endoscopic intragastrical process,
where the inflated silicone balloon is implanted in the stomach and is
remembered there for 6-12 months. It is
extensively known as weight defeat balloon that is considered to support the
individuals to eat less and feel full preferably while eating. This created
less room for the food and effectively supports the body to adapt to healthy
portions. This process is non-surgical, non-invasive, and demands no-incision.
However, this process is not everlasting and assists individual to drop up to
three times the weight when associated to diet alone. Apart from the weight
loss it has several other health benefits as it supports in developing
diabetes, manages cardiac health, and enhances other bone-related issues.
Hence, with the effective advantages the global market of intragastric balloon
will grow more positively in the coming years.
According to the report analysis, ‘Global
Intragastric Balloon Market: Drivers, Opportunities, Trends and Forecast
2017-2023’ states that there are several key players which are
presently functioning in this sector more actively for leading the fastest
market growth and dominating the handsome value of market share across the
globe throughout the short span of time while emerging the endo-bariatric
technology for treating the obesity, effective rise in the prevalence for the
chronic diseases and rising the popularity of outpatient process includes
Apollo Endosurgery, Spatz FGIA, ReShape Medical, and Obalon Therapeutics, and
other predominant & niche players. Moreover, the players of this market in
the underdeveloped regions are decreasing the cost of intragastric balloons
with the significant increase in the spending over the several research and
development programs and developing the proper reimbursement policies which
further benefitted for generating the high amount of revenue in the coming
years.
The Global Intragastric Balloon Market is estimated to
witness a CAGR of 9.6% during the forecast period 2017-2023. Whereas, the
intragastric balloon suggests non-surgical and less invasive endoscopic process
with the reversible weight measurement that has increased in the scale with
tougher impression on the market. Therefore, as more EBT (Endoscopic Bariatric
Therapies) are obtainable for the obese patients it will turn into more
practicable and effective to assist long-term treatment in the near years.
However, the EBT have shown greater results and less adverse events as the
delivery of EBT needs the special room facility and preparation that will
accommodate the size, weight, and surgical gowns for the patient.
Additionally, based on the region, the market of
intragastric balloon is spread across the globe which effectively includes
North America, Europe, Asia Pacific, and Rest of the World (RoW). However, the
Americas is set to be the significant region for the intragastric balloon
market growth followed by Europe. Asia Pacific region and RoW are set to be the
emerging regions. The emerging markets have an extraordinary potential to
increase due to an increase in the number of obese populace and its related
chronic syndromes.
Although, the market in the developed regions are
sighting an effective increase in the acceptance of gastric balloons,
particularly in the US, Canada, France, Germany, and the UK and few of the
Middle East Countries. These regions have the highest obese populace accounting
to 70% to 75% of the total obese population globally. Therefore, in the near
future, it is predicted that the market of intragastric balloon will increase
more positively over the recent few years.
To know more, click on the link below:-
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249
